Alliance Wealth Advisors (Pennsylvania)’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Alliance Wealth Advisors (Pennsylvania)’s Portfolio FLXN Stock Details FLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-18,275	Closed	-$111K	–	120
2021 Q3	$111K	Buy	18,275 +5,300	+41%	+$33K	0.1%	114
2021 Q2	$107K	Hold	12,975	–	–	0.1%	111
2021 Q1	$116K	Hold	12,975	–	–	0.11%	104
2020 Q4	$150K	Buy	+12,975	New	+$151K	0.16%	100

Alliance Wealth Advisors (Pennsylvania)'s FLXN Position: Q4 2021 in Review

Alliance Wealth Advisors (Pennsylvania) sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2021, closing a stake of 18,275 shares — an estimated $111K sold.

Alliance Wealth Advisors (Pennsylvania) first reported a position in FLXN in Q4 2020 and held it in 4 quarters. The position peaked at $150K in Q4 2020. 1 fund tracked by Wall St. Rank holds FLXN as of Q4 2021.

Alliance Wealth Advisors (Pennsylvania) reported no remaining Flexion Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
Alliance Wealth Advisors (Pennsylvania) sold 18,275 Flexion Therapeutics, Inc. shares in Q4 2021, an estimated $111K.
Alliance Wealth Advisors (Pennsylvania) first reported a position in Flexion Therapeutics, Inc. in Q4 2020 and held it in 4 quarters.
Alliance Wealth Advisors (Pennsylvania)'s Flexion Therapeutics, Inc. position peaked at $150K in Q4 2020.
1 fund tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2021.

Based on Alliance Wealth Advisors (Pennsylvania)'s 13F filing for Q4 2021, filed 21 Jan 2022.